PAVmed (PAVM) Accumulated Expenses (2015 - 2026)

PAVmed's Accumulated Expenses history runs 11 years deep, the most recent figure standing at $2.5 million for Q4 2025.

• In Q4 2025, Accumulated Expenses fell 51.97% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $2.5 million (down 51.97% YoY), while the FY2025 annual figure was $2.5 million, down 51.97% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $2.5 million, down from $2.7 million in the prior quarter.
• The five-year high for Accumulated Expenses was $6.8 million in Q2 2024, with the low at $1.1 million in Q1 2021.
• The 5-year median for Accumulated Expenses is $3.2 million (2022), against an average of $3.6 million.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses soared 208.74% in 2022, then tumbled 65.69% in 2025.
• PAVmed's Accumulated Expenses stood at $4.3 million in 2021, then fell by 13.01% to $3.7 million in 2022, then soared by 78.84% to $6.6 million in 2023, then slipped by 21.88% to $5.2 million in 2024, then plunged by 51.97% to $2.5 million in 2025.
• Business Quant data shows PAVM's Accumulated Expenses at $2.5 million in Q4 2025, $2.7 million in Q3 2025, and $2.8 million in Q2 2025.